Gene · 241
Papers2,196
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,196
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology. | Int J Environ Res Public Health | 2021 | 34574768 | PubTator, text mining | PubMed |
| Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives. | Biomedicines | 2021 | 34572346 | PubTator, text mining | PubMed |
| Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways. | J Lipid Res | 2021 | 34560079 | PubTator, text mining | PubMed |
| Platelet-rich fibrin for root coverage: A plausible approach in periodontal plastic and esthetic surgery. | Ann Afr Med | 2021 | 34558456 | PubTator, text mining | PubMed |
| Identification of transcriptome alterations in the prefrontal cortex, hippocampus, amygdala and hippocampus of suicide victims. | Sci Rep | 2021 | 34552157 | PubTator, text mining | PubMed |
| Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects. | Clin Drug Investig | 2021 | 34546534 | PubTator, text mining | PubMed |
| Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics. | Front Pharmacol | 2021 | 34531741 | PubTator, text mining | PubMed |
| Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma. | Clin Epigenetics | 2021 | 34530900 | PubTator, text mining | PubMed |
| Stroke in Africa: profile, progress, prospects and priorities. | Nat Rev Neurol | 2021 | 34526674 | PubTator, text mining | PubMed |
| Anterolateral Thigh Flap for Reconstruction of an Oropharyngectomy Defect. | Plast Reconstr Surg Glob Open | 2021 | 34513539 | PubTator, text mining | PubMed |
| Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations. | Int J Biol Sci | 2021 | 34512156 | PubTator, text mining | PubMed |
| The kinesin KIF1C transports APC-dependent mRNAs to cell protrusions. | RNA | 2021 | 34493599 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators. | Biochem Pharmacol | 2021 | 34487716 | PubTator, text mining | PubMed |
| Landscape of Immune Microenvironment in Epithelial Ovarian Cancer and Establishing Risk Model by Machine Learning. | J Oncol | 2021 | 34484333 | PubTator, text mining | PubMed |
| Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells. | Cytokine Growth Factor Rev | 2021 | 34479816 | PubTator, text mining | PubMed |
| Implementing fluorescence enhancement, quenching, and FRET for investigating flap endonuclease 1 enzymatic reaction at the single-molecule level. | Comput Struct Biotechnol J | 2021 | 34471492 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage. | Front Oncol | 2021 | 34434898 | PubTator, text mining | PubMed |
| PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain. | Nat Commun | 2021 | 34429434 | PubTator, text mining | PubMed |
| Destination Design msTRAM: For Greater Reconstructive Certainty. | Plast Reconstr Surg Glob Open | 2021 | 34422522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/241/papers?page=27